Has Paul Dunn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $28,210 in general payments to Paul Dunn, MD across 1,031 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Dunn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Dunn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Dunn, MD

Dermatology · Spokane Valley, WANPI 1386619294

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $18,411 of the $28,210 with a category attached, or 65.3%. It is spread thinly across 32 manufacturers, the largest accounting for just 17.3%. Reporting peaked in 2023 at $8,857 and has fallen 61.4% since, to $3,418 in 2025. Among dermatology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,210in general payments, 2019–2025

Across 1,031 payments — averaging $27.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

UCB, Inc.$5K
AbbVie$4K
E.r. Squibb & Sons, L.L.C.$4K
Ortho Dermatologics, A Division Of Bausch Health US, LLC$3K
Johnson & Johnson$3K
Novartis$2K
plus $7K from 26 others

What the payments were for

Consulting fees$7,89328%
Travel & lodging$1,2254%
Food & beverage$18,41165%
Education$6812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
UCB, Inc.	110	$4,892
AbbVie(2 entities)	227	$4,114
E.r. Squibb & Sons, L.L.C.	50	$3,668
Ortho Dermatologics, A Division Of Bausch Health US, LLC	39	$3,406
Johnson & Johnson	158	$2,913
Novartis	85	$1,949
Lilly USA, LLC	86	$1,614
Arcutis Biotherapeutics, Inc.	14	$907
Pfizer	61	$685
Sun Pharmaceutical Industries Inc.	30	$592
Amgen	26	$508
Sanofi	20	$463
Galderma Laboratories, L.p.	38	$431
Regeneron Healthcare Solutions, Inc.	18	$400
Dermavant Sciences, Inc.	9	$367
Genentech USA, Inc.	16	$244
Boehringer Ingelheim	5	$213
LEO Pharma Inc.	8	$185
Incyte Corporation	9	$173
Eli Lilly	1	$99
Bristol Myers Squibb	3	$62
Biowound Solutions, Inc.	2	$56
Almirall LLC	2	$50
Prugen, Inc. Pharmaceuticals	3	$44
Biofrontera Inc.	2	$37
Nobelpharma America, LLC	2	$29
Helsinn Therapeutics (U.S.), Inc.	2	$26
Taro Pharmaceuticals USA, Inc.	1	$21
Kyowa Kirin, Inc.	1	$18
Fresenius Kabi USA, LLC	1	$17
Nabriva Therapeutics, PLC	1	$15
Organon	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Sotyktu$2,992
SILIQ$2,681
COSENTYX$592
Tremfya$414
Bimzelx$244
Rinvoq$221
SPEVIGO$125

How this compares

$28,210 in reported general payments places this provider in the 95th percentile of 323 dermatology providers in Washington.

See all dermatology providers in Washington →

Medicare billing

Part B allowed, 2024

$915,217

Medicare patients

3,466

Services billed

11,710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Skyrizi PenRisankizumab-Rzaa	42	$882,488
Cosentyx Unoready PenSecukinumab	48	$383,303
Humira(Cf) PenAdalimumab	31	$353,290
Bimzelx AutoinjectorBimekizumab-Bkzx	13	$195,437
Dupixent PenDupilumab	43	$188,351
Cosentyx Sensoready (2 Pens)Secukinumab	21	$154,816
Dupixent SyringeDupilumab	26	$106,876
Taltz AutoinjectorIxekizumab	13	$87,413
XolairOmalizumab	11	$29,616
Clobetasol Propionate	269	$13,751
Acitretin	34	$7,862
Fluticasone Propionate	221	$5,061
Fluocinonide	85	$4,804
Doxycycline Hyclate	191	$3,361
Dapsone	30	$3,033

Paid to pharmacies, not to this prescriber.

Other dermatology in Spokane Valley

Scott SmithSpokane Valley$9K
Clive LiuBellevue$2.9M
Vivian ShiSeattle$971K
William WerschlerSpokane$948K
Daniel LevyBonney Lake$541K
Daniel SugaiBellevue$302K
Ting-Lin YangBellingham$124K
James CollyerSeattle$115K
Cameron ChesnutSpokane$93K
Alison YoungSeattle$53K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →